Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil

Detalhes bibliográficos
Autor(a) principal: Souza,Gabriela de Oliveira
Data de Publicação: 2016
Outros Autores: Tibúrcio,Aline Andréia Caixeta Magalhães, Koike,Márcia Kiyomi
Tipo de documento: Artigo
Idioma: eng
Título da fonte: MedicalExpress (São Paulo. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005
Resumo: OBJECTIVE: This study aimed to assess the adherence to antiretroviral treatment of HIV-infected patients at the Centro de Referência Viva Vida in Patos de Minas, Minas Gerais, Brazil. METHODS: As a descriptive and quantitative retrospective cross-sectional study, we enlisted HIV-infected patients, over 18 years old, users of highly active antiretroviral therapy (HAART) from June 2011 to July 2012. Data on withdrawal of medication and viral load were collected from the drug logistics management information system and from the medical records, respectively. Sociodemographic and data regarding HAART use were collected manually, using appropriate forms. The CEAT-HIV questionnaire was filled out by140 patients who were using HAART. For data analysis, we used ANOVA and Kruskal-Wallis Rank Sum tests, complemented with Dunn's test, when necessary. P < 0.05 was adopted as the limit for significance. RESULTS: The age group 18-30 years presented lower adherence compared with the group aged over 60 years (p = 0.047). Regarding the HAART usage time, there was no difference between groups (p = 0.515). For the number of pills taken per day, there was greater adherence for patients taking up to 4 pills compared to those taking 5-10 pills daily (p = 0.037). Concerning adherence measured by the CEAT-HIV questionnaire, there was strict/rigorous adherence in 57.8% of patients, with 21.4% of the patients classified as having adequate adherence, according to the data on dispensation of medicines. CONCLUSION: Patients participating in HAART and taking up to 4 pills had good adherence to treatment.
id METC-1_19be9b206260343ece2554323f2f2e36
oai_identifier_str oai:scielo:S2358-04292016000300005
network_acronym_str METC-1
network_name_str MedicalExpress (São Paulo. Online)
repository_id_str
spelling Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, BrazilAdherenceComplianceHAARTHIV/AIDS OBJECTIVE: This study aimed to assess the adherence to antiretroviral treatment of HIV-infected patients at the Centro de Referência Viva Vida in Patos de Minas, Minas Gerais, Brazil. METHODS: As a descriptive and quantitative retrospective cross-sectional study, we enlisted HIV-infected patients, over 18 years old, users of highly active antiretroviral therapy (HAART) from June 2011 to July 2012. Data on withdrawal of medication and viral load were collected from the drug logistics management information system and from the medical records, respectively. Sociodemographic and data regarding HAART use were collected manually, using appropriate forms. The CEAT-HIV questionnaire was filled out by140 patients who were using HAART. For data analysis, we used ANOVA and Kruskal-Wallis Rank Sum tests, complemented with Dunn's test, when necessary. P < 0.05 was adopted as the limit for significance. RESULTS: The age group 18-30 years presented lower adherence compared with the group aged over 60 years (p = 0.047). Regarding the HAART usage time, there was no difference between groups (p = 0.515). For the number of pills taken per day, there was greater adherence for patients taking up to 4 pills compared to those taking 5-10 pills daily (p = 0.037). Concerning adherence measured by the CEAT-HIV questionnaire, there was strict/rigorous adherence in 57.8% of patients, with 21.4% of the patients classified as having adequate adherence, according to the data on dispensation of medicines. CONCLUSION: Patients participating in HAART and taking up to 4 pills had good adherence to treatment.Mavera Edições Técnicas e Científicas Ltda2016-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005MedicalExpress v.3 n.3 2016reponame:MedicalExpress (São Paulo. Online)instname:Mavera Edições Científicas e Técnicas Ltda-MEinstacron:METC10.5935/MedicalExpress.2016.03.05info:eu-repo/semantics/openAccessSouza,Gabriela de OliveiraTibúrcio,Aline Andréia Caixeta MagalhãesKoike,Márcia Kiyomieng2016-06-14T00:00:00Zoai:scielo:S2358-04292016000300005Revistahttp://www.medicalexpress.net.brhttps://old.scielo.br/oai/scielo-oai.php||medicalexpress@me.net.br2358-04292318-8111opendoar:2016-06-14T00:00MedicalExpress (São Paulo. Online) - Mavera Edições Científicas e Técnicas Ltda-MEfalse
dc.title.none.fl_str_mv Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
title Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
spellingShingle Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
Souza,Gabriela de Oliveira
Adherence
Compliance
HAART
HIV/AIDS
title_short Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
title_full Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
title_fullStr Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
title_full_unstemmed Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
title_sort Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
author Souza,Gabriela de Oliveira
author_facet Souza,Gabriela de Oliveira
Tibúrcio,Aline Andréia Caixeta Magalhães
Koike,Márcia Kiyomi
author_role author
author2 Tibúrcio,Aline Andréia Caixeta Magalhães
Koike,Márcia Kiyomi
author2_role author
author
dc.contributor.author.fl_str_mv Souza,Gabriela de Oliveira
Tibúrcio,Aline Andréia Caixeta Magalhães
Koike,Márcia Kiyomi
dc.subject.por.fl_str_mv Adherence
Compliance
HAART
HIV/AIDS
topic Adherence
Compliance
HAART
HIV/AIDS
description OBJECTIVE: This study aimed to assess the adherence to antiretroviral treatment of HIV-infected patients at the Centro de Referência Viva Vida in Patos de Minas, Minas Gerais, Brazil. METHODS: As a descriptive and quantitative retrospective cross-sectional study, we enlisted HIV-infected patients, over 18 years old, users of highly active antiretroviral therapy (HAART) from June 2011 to July 2012. Data on withdrawal of medication and viral load were collected from the drug logistics management information system and from the medical records, respectively. Sociodemographic and data regarding HAART use were collected manually, using appropriate forms. The CEAT-HIV questionnaire was filled out by140 patients who were using HAART. For data analysis, we used ANOVA and Kruskal-Wallis Rank Sum tests, complemented with Dunn's test, when necessary. P < 0.05 was adopted as the limit for significance. RESULTS: The age group 18-30 years presented lower adherence compared with the group aged over 60 years (p = 0.047). Regarding the HAART usage time, there was no difference between groups (p = 0.515). For the number of pills taken per day, there was greater adherence for patients taking up to 4 pills compared to those taking 5-10 pills daily (p = 0.037). Concerning adherence measured by the CEAT-HIV questionnaire, there was strict/rigorous adherence in 57.8% of patients, with 21.4% of the patients classified as having adequate adherence, according to the data on dispensation of medicines. CONCLUSION: Patients participating in HAART and taking up to 4 pills had good adherence to treatment.
publishDate 2016
dc.date.none.fl_str_mv 2016-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292016000300005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/MedicalExpress.2016.03.05
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Mavera Edições Técnicas e Científicas Ltda
publisher.none.fl_str_mv Mavera Edições Técnicas e Científicas Ltda
dc.source.none.fl_str_mv MedicalExpress v.3 n.3 2016
reponame:MedicalExpress (São Paulo. Online)
instname:Mavera Edições Científicas e Técnicas Ltda-ME
instacron:METC
instname_str Mavera Edições Científicas e Técnicas Ltda-ME
instacron_str METC
institution METC
reponame_str MedicalExpress (São Paulo. Online)
collection MedicalExpress (São Paulo. Online)
repository.name.fl_str_mv MedicalExpress (São Paulo. Online) - Mavera Edições Científicas e Técnicas Ltda-ME
repository.mail.fl_str_mv ||medicalexpress@me.net.br
_version_ 1754734597046796288